1-4 of 4
Lucia Zanetta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Study of NMS-03592088, a FLT3, KIT and CSF1R Inhibitor, in Patients with Relapsed or Refractory AML or CMML

Marina Ciomei, Lucia Zanetta, Federico Lussana, MD, Erika Ravelli, MD, Francesco Fiorentini, Roberta Bosotti, Elena Ardini, Andrea Lombardi Borgia, Romana Pulci, Rosalinda Gatto, Alessandro Di Sanzo, Elena Colajori, MD, Cristina Davite, Arturo Galvani, Frank Xiaodong Gan, Giuseppe Rossi, Matteo Giovanni Della Porta, MD, Roberto Cairoli, MD, Alessandro Rambaldi, MD, Antonella Isacchi
Journal: Blood
Blood (2019) 134 (Supplement_1): 3855.
https://doi.org/10.1182/blood-2019-121954
Published: 2019
Journal Articles

VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly

Christopher V. Crosby, Paul A. Fleming, W. Scott Argraves, Monica Corada, Lucia Zanetta, Elisabetta Dejana, Christopher J. Drake
Journal: Blood
Blood (2005) 105 (7): 2771–2776.
https://doi.org/10.1182/blood-2004-06-2244
Published: 2005
Journal Articles

Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis

Raffaella Spagnuolo, Monica Corada, Fabrizio Orsenigo, Lucia Zanetta, Ulrich Deuschle, Peter Sandy, Claudio Schneider, Christopher J. Drake, Ferruccio Breviario, Elisabetta Dejana
Journal: Blood
Blood (2004) 103 (8): 3005–3012.
https://doi.org/10.1182/blood-2003-07-2459
Published: 2004
Journal Articles

A monoclonal antibody to vascular endothelial–cadherin inhibits tumor angiogenesis without side effects on endothelial permeability

Monica Corada, Lucia Zanetta, Fabrizio Orsenigo, Ferruccio Breviario, Maria Grazia Lampugnani, Sergio Bernasconi, Fang Liao, Daniel J. Hicklin, Peter Bohlen, Elisabetta Dejana
Journal: Blood
Blood (2002) 100 (3): 905–911.
https://doi.org/10.1182/blood.V100.3.905
Published: 2002